Company

Diagonal Therapeutics

https://diagonaltx.com/

Industrybiotechnology company developing disease-modifying clustering antibodies that correct dysregulated signaling in severe genetic diseases

Funding raised

CompanyRoundDate
Diagonal TherapeuticsSeries B2026-01-09
Diagonal TherapeuticsFinancing2024-04-04